Clinical Trials

Liver Neoplasms

NCT02984566 2026-05-19

TROG1703 LARK

32 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05146297 2026-05-19

DISRUPT

BreastGastrointestinalGenitourinary

585 enrolled

Breast Neoplasms, Liver Neoplasms, Prostatic Neoplasms

NCT06626087 2026-05-15

Hepatocellular

300 enrolled

Phase 2 Not yet recruiting

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07586046 2026-05-14

MARGIN

30 enrolled

Margins of Excision, Carcinoma, Hepatocellular, Liver Neoplasms

NCT06673329 2026-05-13

Brodalumab in the Treatment of Immune-Related Adverse Events

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

11 enrolled

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Mouth Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Thyroid Neoplasms

NCT07583381 2026-05-13

A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases

107 enrolled

Liver Neoplasms, Colorectal Neoplasms

NCT06794073 2026-05-11

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

17 enrolled

Adenocarcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms, Glandular and Epithelial

NCT06852820 2026-05-08

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

10 enrolled

Phase EARLY_PHASE1 Active not recruiting

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03143270 2026-05-07

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

20 enrolled

Phase 1 Not yet recruiting

Liver Neoplasms

NCT07430202 2026-05-06

A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

27 enrolled

Phase 2 Not yet recruiting

Fibrolamellar hepatocellular carcinoma, Carcinoma, Liver Neoplasms

NCT07226063 2026-05-05

Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer

16 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05718882 2026-04-30

Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

Phase NA Terminated

5 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07053072 2026-04-23

PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.

9 enrolled

Phase 2 Not yet recruiting

Liver Neoplasms

NCT06855225 2026-04-17

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

29 enrolled

Phase NA Enrolling by invitation

Liver Neoplasms

NCT07537205 2026-04-17

The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol

92 enrolled

Liver Neoplasms

NCT06753136 2026-04-13

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

DermatologicGastrointestinal

24 enrolled

Carcinoma, Squamous Cell, Liver Neoplasms, Melanoma, Carcinoma, Merkel Cell

NCT07192172 2026-04-13

ERFA

100 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04715191 2026-04-06

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

GastrointestinalGenitourinarySarcoma

24 enrolled

Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Endodermal Sinus Tumor, Rhabdoid Tumor

NCT07504367 2026-03-31

Large Language Models Assist in Tumor MDT

BreastGastrointestinalThoracic

60 enrolled

Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT03408665 2026-03-30

STEREOLIVER

280 enrolled

Liver Neoplasms

NCT07312292 2026-03-30

RADIANT

15 enrolled

Phase 2 Active not recruiting

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT05622136 2026-03-27

STRAT-aHCC

28 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05128032 2026-03-19

PEDIR

20 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Colorectal Neoplasms

NCT07044362 2026-03-19

Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis

100 enrolled

Liver Neoplasms, Colorectal Neoplasms

NCT01165346 2026-03-13

CKNO-HEP

Phase 2 Completed

44 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03151213 2026-03-13

pregabalin

Phase 4 Completed

70 enrolled

Liver Neoplasms

NCT05095714 2026-03-12

FASTRAK

944 enrolled

Phase 1 Not yet recruiting

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT07436988 2026-03-12

ReLIVE

18 enrolled

Phase 1 Active not recruiting

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03028311 2026-03-10

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

12 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05743842 2026-03-09

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

19 enrolled

Liver Neoplasms

NCT07459309 2026-03-09

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

20 enrolled

Phase 1 Active not recruiting

Liver Neoplasms, Neoplasm Metastasis

NCT05103631 2026-03-06

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

12 enrolled

GastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Endodermal Sinus Tumor, Rhabdoid Tumor

NCT04785287 2026-03-03

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Phase 1/2 Terminated

13 enrolled

EndocrineGastrointestinalThoracic

Adrenal Gland Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT07447050 2026-03-03

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

24 enrolled

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT04134559 2026-02-24

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

18 enrolled

Phase NA Enrolling by invitation

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms

NCT06458998 2026-02-23

GTI

30,300 enrolled

Colonic Neoplasms, Fibrosis, Liver Neoplasms

NCT04258813 2026-02-20

ONE TEAM

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

313 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus, Esophageal Neoplasms, Head and Neck Neoplasms, Hypercholesterolemia, Hypertension, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

EndocrineGastrointestinalNET

360 enrolled

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT06958224 2026-02-20

ESCAT

360 enrolled

BreastGastrointestinal

Breast Neoplasms, Liver Neoplasms

NCT06608940 2026-02-19

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

Phase 1/2 Withdrawn

Liver Neoplasms

NCT07407257 2026-02-18

SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors

65 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Carcinoma, Hepatocellular, Liver Neoplasms, Pancreatic Neoplasms

NCT07410494 2026-02-18

SELECT-CAR-NK

Phase 1/2 Recruiting

85 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT07410676 2026-02-18

EBNK-ST-001

Phase 1/2 Recruiting

83 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Bronchogenic, Disease, Esophageal Neoplasms, Glioblastoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT06261814 2026-02-17

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

266 enrolled

Liver Neoplasms

NCT07148050 2026-02-17

IMPACT

GastrointestinalGenitourinarySarcoma

21 enrolled

Carcinoma, Hepatocellular, Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Hepatoblastoma, Endodermal Sinus Tumor, Rhabdoid Tumor

NCT07297615 2026-02-17

3D Liver Volumetry

25 enrolled

Liver Neoplasms

NCT04288323 2026-02-12

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

Phase 4 Completed

79 enrolled